Cargando…

Secondary Use of Data: Non-Interventional Study Best Practices in Planning and Protocol Development

Well established guidelines already exist that address best practices for Non-Interventional Study (NIS) design and methods. These guidelines provide advice on things to consider while designing a study and developing a protocol, but do not necessarily capture specific details related to the impleme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Juanzhi, Bruce Wirta, Sara, Kahler, Kristijan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Columbia Data Analytics, LLC 2017
Materias:	Methodology and Healthcare Policy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471405/ https://www.ncbi.nlm.nih.gov/pubmed/37664689 http://dx.doi.org/10.36469/9796

Ejemplares similares

Impact of Oxycodone HCl Extended-release Formulary Restrictions on Extended-release Opioid Market Share, Healthcare Resource Utilization and Costs in Commercial and Medicare Plans
por: Wade, Rolin L., et al.
Publicado: (2017)

Validity and Reliability Analysis of Knowledge of, Attitude toward and Practice of a Case-mix Questionnaire among Turkish Healthcare Providers
por: Ali Jadoo, Saad Ahmed, et al.
Publicado: (2014)

A Criterion-based Approach for the Systematic and Transparent Extrapolation of Clinical Trial Survival Data
por: Tremblay, Gabriel, et al.
Publicado: (2015)

A Characterisation and Profiling of District Health Indicators in Zimbabwe: An Application of Principal Component Analysis in a Data Limited Setting
por: Shamu, Shepherd, et al.
Publicado: (2015)

No Apparent Workup for most new Indeterminate Pulmonary Nodules in US Commercially-Insured Patients
por: Pyenson, Bruce S., et al.
Publicado: (2019)

Estimating the Prevalence of Opioid use Disorder in the Cincinnati Region using Probabilistic Multiplier Methods and Model Averaging
por: Mallow, Peter J., et al.
Publicado: (2019)

Health Inequalities in Under-Five Mortality: An Assessment of Empowered Action Group (EAG) States of India
por: Kumar, Sarvesh, et al.
Publicado: (2020)

The Impact of Recent Generic Drug Price Policies on Pharmaceutical Innovation: A Theoretical Rationale and Proposal of a Method Supporting Innovation in Areas of Unmet Medical Need
por: Dionne, Pierre-Alexandre, et al.
Publicado: (2016)

Using Deep Learning to Identify High-Risk Patients with Heart Failure with Reduced Ejection Fraction
por: Wang, Zhibo, et al.
Publicado: (2021)

Estimating Potential for Drug Budget Reallocation Following Expiration of Exclusivity of Pharmaceutical Products
por: Toghanian, Samira, et al.
Publicado: (2022)

The Merit-based Incentive Payment System: Pearson’s Chi-Square and Categorical Dependent Variable Models Analyzed for Domains—Effective Clinical Care and Efficiency/Cost Reduction
por: Shenoy, Amrita
Publicado: (2021)

The Potential Cost and Cost-Effectiveness Impact of Using a Machine Learning Algorithm for Early Detection of Sepsis in Intensive Care Units in Sweden
por: Ericson, Oskar, et al.
Publicado: (2022)

A Standardized Framework for Evaluating Surgical Enhanced Recovery Pathways: A Recommendations Statement from the TDABC in Health-care Consortium
por: Etges, Ana Paula B.S., et al.
Publicado: (2021)

Mobile Integrated Healthcare: Preliminary Experience and Impact Analysis with a Medicare Advantage Population
por: Castillo, Daniel J., et al.
Publicado: (2016)

Translation of the UK Pediatric Influenza Vaccination Programme in Primary Schools to 13 European Countries Using a Dynamic Transmission Model
por: Gerlier, Laetitia, et al.
Publicado: (2017)

The Impacts of Breakthrough Drug Classes on Total Healthcare Expenditures
por: Karaca, Zeynal, et al.
Publicado: (2016)

Lifetime Health Care Costs of the Danish Population
por: Sørensen, Jan, et al.
Publicado: (2013)

Creating National Weights for a Patient-level Longitudinal Database
por: Baser, Onur, et al.
Publicado: (2016)

Comparing Health Care Financing in Indonesia and Thailand from 1995-2010: What Lessons Could Be Learned?
por: Erlangga, Darius, et al.
Publicado: (2013)

What Drives Responses to Willingness-to-pay Questions? A Methodological Inquiry in the Context of Hypertension Self-management
por: Kaambwa, Billingsley, et al.
Publicado: (2016)

Cost of Intravenous Analgesia for the Management of Acute Pain in the Emergency Department is Substantial in the United States
por: Palmer, Pamela P., et al.
Publicado: (2017)

Effectiveness of a Patient Support Program in Supporting Access to Therapy for Solid Tumor Malignancies
por: Parker, Lindsay, et al.
Publicado: (2016)

Direct and Indirect Protection with Pediatric Quadrivalent Live-Attenuated Influenza Vaccination in Europe Estimated by a Dynamic Transmission Model
por: Gerlier, Laetitia, et al.
Publicado: (2017)

Use of Open Claims vs Closed Claims in Health Outcomes Research
por: Baser, Onur, et al.
Publicado: (2023)

Secondary Analyses of Large Population-Based Data Sets: Issues of Quality, Standards, and Understanding
por: Ko, Clifford Y., et al.
Publicado: (2007)

Health Coaching: Adding Value in Healthcare Reform
por: May, Coral S., et al.
Publicado: (2013)

Impact of the Introduction of Calcimimetics on Timing of Parathyroidectomy in Secondary and Tertiary Hyperparathyroidism
por: van der Plas, Willemijn Y., et al.
Publicado: (2016)

Does Practice Make Perfect?
por: Hogan, A. M., et al.
Publicado: (2008)

An evaluation of emergency general surgery transfers and a call for standardization of practices
por: Bruenderman, Elizabeth H., et al.
Publicado: (2021)

The National Cancer Data Base: Past, Present, and Future
por: Winchester, David P., et al.
Publicado: (2009)

EMQN/CMGS best practice guidelines for the molecular genetic testing of Huntington disease
por: Losekoot, Monique, et al.
Publicado: (2013)

The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States
por: Bilimoria, Karl Y., et al.
Publicado: (2008)

EMQN best practice guidelines for genetic testing in dystrophinopathies
por: Fratter, Carl, et al.
Publicado: (2020)

Genetic testing for mitochondrial disease: the United Kingdom best practice guidelines
por: Mavraki, Eleni, et al.
Publicado: (2022)

A video of best practice recommendations for making botulinum toxin therapy safe during the COVID-19 pandemic
por: Bono, Francesco, et al.
Publicado: (2021)

EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH)
por: Porto, Graça, et al.
Publicado: (2016)

Creating a best practice template for participant communication plans in global health clinical studies
por: Shelly, Colleen E., et al.
Publicado: (2023)

Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2
por: Kamsteeg, Erik-Jan, et al.
Publicado: (2012)

EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency
por: Baumgartner-Parzer, Sabina, et al.
Publicado: (2020)

EMQN Best Practice Guidelines for molecular and haematology methods for carrier identification and prenatal diagnosis of the haemoglobinopathies
por: Traeger-Synodinos, Joanne, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_d3tqgcp3apqiidcphkd7e5odlu